WallStreetZen

NYSE: ABBV
AbbVie Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

ABBV past earnings growth

How has ABBV's earnings growth performed historically?
Company
109.25%
Industry
12.52%
Market
38.18%
ABBV's earnings have grown faster (22.39% per year) than the US Drug Manufacturers - General industry average (6.08%)
Performance
ABBV's earnings have grown slower (22.39% per year) than the US market average (28.61%)
Performance
ABBV's earnings growth is accelerating - its growth over the last year (109.25%) is above its 5-year compound annual rate (22.39%)
Performance

ABBV past revenue growth

How has ABBV's revenue growth performed historically?
Company
23.68%
Industry
8.9%
Market
16%
ABBV's revenue has grown faster (13.16% per year) than the US Drug Manufacturers - General industry average (4.25%)
Performance
ABBV's revenue has grown slower (13.16% per year) than the US market average (16.19%)
Performance
ABBV's revenue growth is accelerating - its growth over the last year (23.68%) is above its 5-year compound annual rate (13.16%)
Performance

ABBV earnings and revenue history

Current Revenue
$40.7B
Current Earnings
$7.4B
Current Profit Margin
18.2%

ABBV Return on equity

Current Company
205.2%
Current Industry
55.3%
Current Market
23.9%
ABBV's Return on Equity (205.2%) shows a company that is highly efficient at transforming shareholder equity into returns
Performance

ABBV Return on assets

Current Company
6.2%
Current Industry
8.6%
Current Market
6.2%
ABBV is generating lower Return on Assets (6.2%) than the US Drug Manufacturers - General industry average (8.23%)
Performance

ABBV Return on capital employed

Current Company
8.05%
Current Industry
12.8%
ABBV's ability to generate Return on Capital (8.05%) has decreased compared to 3 years ago (17.16%)
Performance

ABBV earnings dates

Next earnings date
Feb 3, 2021

AbbVie Earnings & Revenue FAQ

What were ABBV's earnings last quarter?

On Oct 30, 2020, AbbVie (NYSE: ABBV) reported Q3 2020 earnings per share (EPS) of $1.30, up 2.36% year over year. Total AbbVie earnings for the quarter were $2.31 billion. In the same quarter last year, AbbVie's earnings per share (EPS) was $1.27.

What was ABBV's revenue last quarter?

On Oct 30, 2020, AbbVie (NYSE: ABBV) reported Q3 2020 revenue of $12.90 billion up 52.16% year over year. In the same quarter last year, AbbVie's revenue was $8.48 billion.

What was ABBV's earnings growth in the past year?

As of Q1 2021, AbbVie's earnings has grown 109.25% year over year. This is 96.73 percentage points higher than the US Drug Manufacturers - General industry earnings growth rate of 12.52%. AbbVie's earnings in the past year totalled $7.38 billion.

What was ABBV's revenue growth in the past year?

As of Q1 2021, AbbVie's revenue has grown 23.68% year over year. This is 14.78 percentage points higher than the US Drug Manufacturers - General industry revenue growth rate of 8.9%. AbbVie's revenue in the past year totalled $40.65 billion.

What is ABBV's earnings date?

AbbVie's earnings date is Feb 03, 2021. Add ABBV to your watchlist to be reminded of ABBV's next earnings announcement.
WallStreetZen
©2021 WallStreetZen
Company
AboutBlogPrivacy PolicyTerms of ServiceContact
Stocks
Stock ScreenerStock ForecastHighest Earnings StocksBest Dividend Paying StocksStatistics
Social
TwitterYouTube
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Heap | Mobile and Web Analytics